SBTech Global Logo

Our Team

Meet the experts behind SBTech Global

Leadership

Click on a card to read the full bio

S

Shmulik Berkovich

Chief Executive Officer

Founder of SBTech Global Consulting with over three decades of multidisciplinary experience in healthcare, pharmaceuticals and biotechnology. Previously Founder & CEO of Medison Pharma (1995–2011), where he built the in-country infrastructure and launched major brands including Biogen, Amgen, Shire, Genzyme, and Cephalon. Earlier, VP Head of Commercial at Novartis Israel. Holds a BSc in Chemistry and an MBA from Tel Aviv University & Wharton School of Business.

H

Hans Peter Hasler

Head Advisor, Global Ventures

Senior executive and top-level advisor to the life-sciences industry with deep international operational and commercial expertise. Former COO at both Biogen and Elan Pharmaceuticals, CMO at Wyeth, and CEO of Vicarius Pharma. Led in-licensing of Tecfidera (>$4B annual revenues) and the global launch of Tysabri at Biogen. Currently Chairman of HBM Healthcare Investments (SIX) and Shield Therapeutics (AIM).

G

Gili Berkovich Amitai

Partner

Experienced lawyer and result-oriented business development leader with over eight years of experience in the biotechnology and pharmaceutical sector. Previously worked at GKH, one of Israel's leading commercial and corporate law firms, where she was actively involved in structuring commercial deals and litigation. Also served as VP of BD at Together Pharma. Holds a BA in Business Administration and LLB in Law from the Interdisciplinary Center Herzliya.

Global Advisory Board

Engaged on a project-specific basis, ensuring focused and discreet support across global markets. Click on a card to read the full bio.

G

Gwen Melincoff

Advisor

Senior biopharma executive and advisor with extensive experience in business development, licensing and strategic partnerships across the pharmaceutical industry.

A

Anthony Sun, MD

Advisor

Former Partner at Aisling Capital ($1.6B AUM healthcare fund), where he sat on numerous private and public company boards from 2002–2015. Previously Adjunct Instructor of Medicine at the Hospital of the University of Pennsylvania. Holds an MD from Temple University, MBA from Wharton, and BS in Electrical Engineering from Cornell.

J

James Hattersley

Advisor

Seasoned pharmaceutical and biotech executive with broad international experience across business development, strategy and commercial operations.

E

Eric Richman

Advisor

Accomplished biopharma executive who served as President & CEO of CombiMatrix (NASDAQ IPO) and President & COO of PharmAthene. Career spanning venture capital at HealthCare Ventures, and senior leadership roles across multiple biotech companies. Currently Chairman of Labconnect Holdings and board member of Gain Therapeutics and Tempo Therapeutics.

C

Christophe Jean

Advisor

40+ year pharmaceutical industry leader with experience across all world markets. Former EVP Strategy & Business Development at Ipsen (2003–2013) and prior senior roles at Ciba-Geigy. Subsequently a Senior Advisor at Bain & Company. Board member of Rhythm Pharmaceuticals and European Biopharmaceutical Enterprises. MBA from Harvard Business School.

K

Klaus Schollmeier, PhD

Advisor

Pharma/Biotech industry advisor and board member with 30+ years of international executive experience. Former CEO of SuppreMol (sold to Baxalta, 2015) and Santhera Pharmaceuticals. Earlier spent 16 years in pharma at BASF, Knoll and Abbott. PhD in Biology from the University of Düsseldorf; Adjunct Research Associate Professor, Boston University Medical School.

M

Mark Wolters, PhD

Advisor

Independent biopharma business development executive with 25+ years of experience. Former VP Business Development & Licensing and Head of Early Licensing at Bayer, where he led pioneering joint ventures including Casebia Therapeutics (with CRISPR Therapeutics) and BlueRock Therapeutics. Also previously Executive Director, Office of Technology at Schering AG. PhD in Molecular Biology, Freie Universität Berlin; post-doctoral training at MIT.

E

Eric Bouteiller

Advisor

Seasoned international healthcare business leader and China expert. Former SVP Asia PC Operations at Ipsen, based in Beijing, and former Chairman of the R&D-based Pharmaceutical Association (RDPAC) in China. Co-founder & Partner at JUMO Partners. Adjunct Professor of Management at CEIBS. PhD in Organisational Sociology. Co-author of "Fundamentals of Market Access for Pharmaceuticals".

J

Jeff Berkovich

Advisor

Business executive and entrepreneur contributing to SBTech's strategic advisory network.

Interested in Partnering with Us?

Contact us to learn more about our strategic partnerships and how we can help your organization

© 2025 SBTech Global. Healthcare Advisory by Executives, for Executives.